AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Byline: Andrew Bulkeley in Berlin
Swiss specialty chemicals group Clariant AG said it may sell units representing 7% of its annual sales and sell shares to keep debt under control and stanch the effects of a strong Swiss franc.
Muttenz, Switzerland-based Clariant said it will separate its pharmaceuticals, custom synthesis, electronic materials and masterbatches units into individual companies in preparation for a possible sale or partnership after the group posted a loss for the second straight year.
The company aims to slash debt below SFr2.5 billion ($1.8 billion) by the end of the year, from the current SFr3.5 billion, by selling the divisions, …